To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DNAJC7TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
546 supporting clones for gene DNAJC7 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CN275414 embryonic stem cells, DMSO-treated H9 cellline .a 1 to 679 1 to 679   tiling clone,   679/679
(100 %)
5 diff
(99.3 %id)
CN275410 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 220 to 968 13 to 762       750/762
(98 %)
9 diff
(98.9 %id)
BX443191 B cells (Ramos cell line) .a 365 to 1179 1 to 820   fully sequenced,   818/818
(100 %)
22 diff
(97.4 %id)
CR600431 B cells (Ramos cell line) .a 367 to 1971 1 to 1605   tiling clone,   1605/1605
(100 %)
0 diff
(100 %id)
BX435838 B cells (Ramos cell line) .a 1149 to 1971 814 to 1   fully sequenced,   814/814
(100 %)
10 diff
(98.8 %id)
BX418120 brain, fetal brain .b 1 to 686 3 to 688   tiling clone,   688/688
(100 %)
0 diff
(100 %id)
DB469501 hippocampus .b 1 to 430 2 to 430       430/430
(100 %)
3 diff
(99.4 %id)
BX446596 neuroblastoma .b 5 to 686 1 to 682       682/682
(100 %)
1 diff
(99.9 %id)
BX418119 brain, fetal brain .b 858 to 1892 1032 to 11   tiling clone,   1022/1038
(98 %)
19 diff
(98.2 %id)
DB453150 testis .c 1 to 494 1 to 494   tiling clone,   494/494
(100 %)
3 diff
(99.4 %id)
NM_003315.3   .c 1 to 2078 1 to 2078   RefSeq, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 2078/2078
(100 %)
0 diff
(100 %id)
BX647209 human salivary gland .c 45 to 2060 1 to 2016 K375R tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 2016/2016
(100 %)
1 diff
(100.0 %id)
DB450402 testis .c 51 to 517 1 to 467       467/467
(100 %)
5 diff
(99.0 %id)
BP298442   .c 74 to 658 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
BP363572 lung .c 168 to 754 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
DA662352   .c 218 to 782 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BP249083 Kidney .c 224 to 806 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA144654 amygdala .c 238 to 809 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
CD691946 normal nasopharynx .c 244 to 810 23 to 588       566/588
(96 %)
8 diff
(98.7 %id)
BG681617 skin, squamous cell carcinoma .c 245 to 1014 1 to 771       771/771
(100 %)
5 diff
(99.4 %id)
BP372220 umbilical cord .c 249 to 822 1 to 574       574/574
(100 %)
0 diff
(100 %id)
BP236848 coronary artery .c 252 to 829 5 to 582       578/582
(99 %)
6 diff
(99.0 %id)
BX424553 neuroblastoma .c 255 to 759 1 to 507       507/512
(99 %)
19 diff
(96.3 %id)
DA469703   .c 255 to 811 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
CX871535 embryonic stem .c 255 to 1047 1 to 793       793/793
(100 %)
1 diff
(99.9 %id)
DA364407 subthalamic nucleus .c 256 to 824 11 to 579   capped   569/569
(100 %)
0 diff
(100 %id)
DB120970 thymus .c 256 to 831 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DC379137 pericardium .c 257 to 827 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
DA467047 cord Blood .c 258 to 828 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BM806089 leiomyosarcoma, uterus .c 258 to 1165 1 to 911       911/1073
(84 %)
15 diff
(98.7 %id)
BP197427 adrenal gland .c 259 to 835 1 to 582       580/582
(99 %)
6 diff
(99.0 %id)
BP197760 adrenal gland .c 259 to 840 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG723911 testis .c 259 to 915 7 to 664       658/664
(99 %)
13 diff
(98.1 %id)
BP273506   .c 259 to 823 1 to 564       564/564
(100 %)
10 diff
(98.3 %id)
AU100176   .c 259 to 558 1 to 300       300/300
(100 %)
4 diff
(98.7 %id)
BP331594 renal proximal tubule .c 259 to 824 1 to 566       566/566
(100 %)
4 diff
(99.3 %id)
DB016588 esophageal, tumor tissue .c 259 to 830 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BP379055 uterus .c 259 to 824 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DA440752 tongue, tumor tissue .c 260 to 806 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BP336510 coronary artery .c 262 to 841 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP337428 coronary artery .c 262 to 845 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BP264674 umbilical vein .c 263 to 838 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
BP281979 bone marrow .c 263 to 848 1 to 587       585/587
(99 %)
1 diff
(99.9 %id)
BM827854 stomach .c 263 to 810 1 to 549       549/549
(100 %)
14 diff
(97.5 %id)
BP351095   .c 263 to 844 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA061140 cerebellum .c 264 to 827 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BU597987 mixed (pool of 40 RNAs) .c 264 to 879 1 to 622       622/836
(74 %)
23 diff
(97.3 %id)
TI_57150214   .c 264 to 1068 22 to 825       804/825
(97 %)
8 diff
(99.1 %id)
BP382577 adipose tissue .c 265 to 880 1 to 616       616/617
(99 %)
2 diff
(99.7 %id)
CN275409 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 265 to 850 1 to 586       586/591
(99 %)
4 diff
(99.4 %id)
BU147030 brain, neuroblastoma, cell line .c 265 to 979 25 to 748       724/911
(79 %)
28 diff
(97.0 %id)
DA775042 brain .c 265 to 847 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
BP327475 prostata .c 265 to 845 1 to 581       581/583
(99 %)
8 diff
(98.7 %id)
BP327457 prostata .c 265 to 845 1 to 581       581/583
(99 %)
8 diff
(98.7 %id)
BP331779 renal proximal tubule .c 265 to 853 1 to 589       589/591
(99 %)
5 diff
(99.2 %id)
BP350932   .c 265 to 847 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA002499   .c 266 to 838 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA373645 thalamus .c 266 to 814 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BU193725 melanotic melanoma, skin .c 266 to 1034 1 to 771       771/876
(88 %)
18 diff
(98.0 %id)
BC033772 Skin, melanotic melanoma. .c 267 to 2020 12 to 1765   available from MGC, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 1754/1754
(100 %)
0 diff
(100 %id)
BI553340 brain, hippocampus .c 267 to 966 6 to 705       700/705
(99 %)
6 diff
(99.2 %id)
TI_44170350   .c 267 to 966 88 to 787       700/787
(88 %)
6 diff
(99.3 %id)
DA032109   .c 268 to 676 2 to 410   capped   409/411
(99 %)
2 diff
(99.6 %id)
DA940698 Spleen .c 268 to 857 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DB045511 testis .c 268 to 826 2 to 559   capped   558/558
(100 %)
3 diff
(99.5 %id)
BG701243 brain, hippocampus .c 269 to 880 1 to 612       612/617
(99 %)
5 diff
(99.2 %id)
DA971305 synovial membrane tissue from rheumatioidarthritis .c 269 to 781 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
BM923113 leukocyte .c 270 to 1142 1 to 877       877/1112
(78 %)
31 diff
(97.3 %id)
BI458274 brain, hypothalamus .c 271 to 1087 1 to 826       826/883
(93 %)
27 diff
(97.0 %id)
BQ694609 adipose .c 272 to 673 1 to 404       404/404
(100 %)
2 diff
(99.6 %id)
CN275413 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 272 to 1031 1 to 760       760/760
(100 %)
0 diff
(100 %id)
CN275415 embryonic stem cells, DMSO-treated H9 cellline .c 272 to 573 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
BX422440 fetal liver, Liver .c 272 to 763 1 to 494       494/494
(100 %)
2 diff
(99.6 %id)
BI763741 pooled colon, kidney, stomach .c 272 to 1068 1 to 796       796/796
(100 %)
2 diff
(99.8 %id)
BG495899 lung, mucoepidermoid carcinoma .c 273 to 1034 1 to 760       760/853
(89 %)
22 diff
(97.5 %id)
CB992052 placenta, pre-eclamptic placenta .c 273 to 1065 28 to 830       803/830
(96 %)
18 diff
(97.9 %id)
CB997316 placenta, pre-eclamptic placenta .c 273 to 945 28 to 705       678/852
(79 %)
15 diff
(98.3 %id)
BM751750 Ascites, stomach .c 273 to 815 1 to 543       543/543
(100 %)
1 diff
(99.9 %id)
U46250 liver cell line, pancreatic cancer .c 273 to 498 1 to 227       227/227
(100 %)
1 diff
(99.6 %id)
DA565698 heart .c 274 to 845 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BQ057829 lymph, lymphoma, cell line .c 274 to 1161 1 to 893       893/1037
(86 %)
4 diff
(99.7 %id)
BQ061653 lymph, lymphoma, cell line .c 274 to 1281 1 to 1026       1026/1092
(93 %)
34 diff
(96.9 %id)
BQ065889 lymph, lymphoma, cell line .c 274 to 1183 1 to 919       919/1024
(89 %)
28 diff
(97.3 %id)
BQ894043 lymph, lymphoma, cell line .c 274 to 844 1 to 572       572/1016
(56 %)
6 diff
(99.5 %id)
BP311035 brain .c 274 to 854 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA965290 stomach .c 274 to 525 2 to 253   capped   252/252
(100 %)
0 diff
(100 %id)
AL703248 human skeletal muscle .c 275 to 761 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
BG338732 leiomyosarcoma cell line, uterus .c 275 to 1027 1 to 742       742/960
(77 %)
23 diff
(97.7 %id)
BP194838 brain .c 276 to 858 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB502966 hypothalamus .c 276 to 756 1 to 481       481/481
(100 %)
3 diff
(99.4 %id)
BP257795 heart .c 276 to 843 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
BP279395   .c 276 to 858 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP334624 salivary gland .c 276 to 850 1 to 574       574/582
(98 %)
5 diff
(99.2 %id)
DA060341 cerebellum .c 277 to 835 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA134423 alzheimer cortex .c 277 to 818 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA139639 alzheimer cortex .c 277 to 845 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA139859 alzheimer cortex .c 277 to 834 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA158999 amygdala .c 277 to 850 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA208495 brain .c 277 to 840 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA382285 thalamus .c 277 to 831 2 to 554   capped   555/553
(100 %)
2 diff
(99.7 %id)
DA441577 tongue, tumor tissue .c 277 to 848 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BP248944 Kidney .c 277 to 856 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BM457333 embryonal carcinoma, cell line, testis .c 277 to 1025 25 to 785       761/1150
(66 %)
31 diff
(97.4 %id)
BU537900 adenocarcinoma, cell line, breast .c 277 to 876 1 to 603       603/884
(68 %)
4 diff
(99.6 %id)
DA947367 Spleen .c 277 to 842 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA959622 Spleen .c 277 to 840 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB158012 thymus .c 277 to 849 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA141172 alzheimer cortex .c 278 to 840 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
CF140273 CNCAP(3)T-225 cell line, Prostate .c 278 to 803 1 to 526       526/526
(100 %)
4 diff
(99.3 %id)
BP309916 brain .c 278 to 860 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BP236949 coronary artery .c 279 to 859 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP262971 small intestine .c 279 to 853 1 to 575       575/575
(100 %)
3 diff
(99.5 %id)
BP279979   .c 279 to 865 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BM828699 Ascites, stomach .c 279 to 858 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BP360614 thalamus .c 279 to 860 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA002040   .c 280 to 836 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA273501 caudate nucleus .c 280 to 827 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
DA538763 Kidney .c 280 to 858 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
BP231921 muscle .c 280 to 726 1 to 447       447/454
(98 %)
5 diff
(98.9 %id)
AU119126 whole embryo, mainly head .c 280 to 1034 2 to 762   capped   761/787
(96 %)
13 diff
(98.4 %id)
BM464668 lymph, lymphoma, cell line .c 280 to 1298 1 to 1022       1022/1120
(91 %)
33 diff
(97.1 %id)
BQ214351 embryonal carcinoma, cell line, testis .c 280 to 1110 1 to 838       838/858
(97 %)
16 diff
(98.2 %id)
DA930532 small intestine .c 280 to 838 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB044200 testis .c 280 to 829 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB267921 uterus .c 280 to 851 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BG912449 anaplastic oligodendroglioma with 1p/19qloss, brain .c 281 to 882 1 to 623       620/970
(63 %)
32 diff
(96.8 %id)
BG912336 anaplastic oligodendroglioma with 1p/19qloss, brain .c 281 to 931 1 to 654       654/654
(100 %)
21 diff
(96.8 %id)
DA007118   .c 282 to 858 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BC011837 Lung, small cell carcinoma .c 282 to 2020 1 to 1739   available from MGC, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 1739/1739
(100 %)
0 diff
(100 %id)
DA288092 corpus callosum .c 282 to 838 2 to 559   capped   558/559
(99 %)
2 diff
(99.7 %id)
DA378575 thalamus .c 282 to 847 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BX337713 Placenta Cot 25-normalized .c 282 to 1197 1 to 918       918/918
(100 %)
36 diff
(96.1 %id)
CV028536 mixed .c 282 to 918 1 to 636       636/636
(100 %)
1 diff
(99.9 %id)
TI_1948133473   .c 282 to 1199 134 to 1054       921/1326
(69 %)
26 diff
(98.1 %id)
TI_1948133474   .c 282 to 1199 132 to 1051       920/1288
(71 %)
29 diff
(97.8 %id)
TI_1948133475   .c 282 to 1167 130 to 1020       891/1158
(76 %)
28 diff
(97.6 %id)
TI_1948134009   .c 282 to 1212 131 to 1054       924/1304
(70 %)
37 diff
(97.2 %id)
TI_1948134010   .c 282 to 1199 139 to 1061       923/1282
(71 %)
28 diff
(97.9 %id)
TI_1948134011   .c 282 to 1034 127 to 882       756/1229
(61 %)
18 diff
(98.6 %id)
TI_1948134554   .c 282 to 1197 125 to 1040       916/1315
(69 %)
18 diff
(98.7 %id)
TI_1948134555   .c 282 to 1196 134 to 1052       919/1296
(70 %)
30 diff
(97.7 %id)
TI_1948134556   .c 282 to 1105 126 to 958       833/1196
(69 %)
25 diff
(98.0 %id)
TI_1948135089   .c 282 to 1199 127 to 1051       925/1336
(69 %)
32 diff
(97.7 %id)
TI_1948135090   .c 282 to 1197 139 to 1057       919/1327
(69 %)
27 diff
(98.0 %id)
TI_1948135091   .c 282 to 1196 126 to 1045       920/1137
(80 %)
40 diff
(96.5 %id)
CN275407 embryonic stem cells, cell lines H1, H7, andH9 .c 283 to 990 1 to 706       706/706
(100 %)
2 diff
(99.8 %id)
BG105985 lymph, lymphoma, cell line .c 283 to 936 1 to 654       654/1024
(63 %)
8 diff
(99.3 %id)
BQ049822 lymph, lymphoma, cell line .c 283 to 1204 1 to 931       931/1026
(90 %)
20 diff
(98.1 %id)
CD616847   .c 284 to 641 1 to 357       357/364
(98 %)
8 diff
(97.9 %id)
BG112512 Bone, osteosarcoma, cell line .c 284 to 929 1 to 648       648/1140
(56 %)
15 diff
(98.7 %id)
BU189577 eye, retinoblastoma .c 284 to 1159 12 to 891       880/926
(95 %)
33 diff
(96.5 %id)
DN993596 brain, whole brain .c 284 to 928 1 to 645       645/645
(100 %)
6 diff
(99.1 %id)
TI_154170671   .c 284 to 964 78 to 764       687/906
(75 %)
19 diff
(98.0 %id)
BM476748 leiomyosarcoma, uterus .c 285 to 1197 1 to 916       916/1088
(84 %)
36 diff
(96.7 %id)
BI757895 brain .c 286 to 1031 1 to 749       749/914
(81 %)
9 diff
(99.1 %id)
BM806093 leiomyosarcoma, uterus .c 286 to 1328 1 to 1051       1051/1062
(98 %)
21 diff
(98.1 %id)
BQ431427 eye, retinoblastoma .c 286 to 1034 1 to 752       752/897
(83 %)
12 diff
(98.7 %id)
TI_57221421   .c 286 to 1031 32 to 780       749/945
(79 %)
15 diff
(98.5 %id)
U46571   .c 286 to 2020 1 to 1735   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 1735/1735
(100 %)
1 diff
(100.0 %id)
BP277611 Kidney .c 287 to 855 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
AV689034 hepatocellular carcinoma .c 289 to 651 1 to 356       359/365
(98 %)
12 diff
(96.8 %id)
BU508542 leiomyosarcoma, uterus .c 289 to 1196 1 to 918       918/937
(97 %)
16 diff
(98.3 %id)
CX759738 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 291 to 999 1 to 708     Submitted on the opposite strand 708/708
(100 %)
2 diff
(99.8 %id)
CX751965 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 291 to 1032 1 to 732       732/861
(85 %)
18 diff
(98.0 %id)
CX865490 embryonic stem .c 292 to 1081 1 to 790       790/790
(100 %)
3 diff
(99.7 %id)
BF172038 blood .c 294 to 605 1 to 312       312/312
(100 %)
6 diff
(98.1 %id)
BP226124   .c 294 to 874 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BM462670 melanotic melanoma, skin .c 295 to 1003 1 to 717       717/1025
(69 %)
22 diff
(97.9 %id)
BQ953232 epidermoid carcinoma, cell line, lung .c 295 to 1169 1 to 883       883/990
(89 %)
33 diff
(96.7 %id)
AK291047   .c 300 to 2027 1 to 1728       1728/1728
(100 %)
4 diff
(99.8 %id)
DA367294 subthalamic nucleus .c 300 to 862 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BE794236 lung, small cell carcinoma .c 301 to 1034 1 to 734       734/1158
(63 %)
12 diff
(99.0 %id)
DA725640   .c 301 to 865 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA358001 subthalamic nucleus .c 302 to 873 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BM464293 leiomyosarcoma, uterus .c 302 to 1298 1 to 998       998/1107
(90 %)
8 diff
(99.3 %id)
BP308670 brain .c 302 to 886 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BE269209 Burkitt lymphoma, lymph .c 303 to 805 1 to 502       502/504
(99 %)
3 diff
(99.5 %id)
DA070743 cerebellum .c 304 to 825 2 to 522   capped   521/521
(100 %)
3 diff
(99.5 %id)
TI_1948132863   .c 304 to 1031 129 to 861       733/1293
(56 %)
17 diff
(98.7 %id)
TI_1948133175   .c 305 to 1034 128 to 864       737/1215
(60 %)
24 diff
(98.1 %id)
BM903921 eye, retinoblastoma .c 306 to 1199 48 to 942       895/997
(89 %)
12 diff
(98.8 %id)
TI_1948132246   .c 306 to 949 123 to 768       646/1372
(47 %)
9 diff
(99.4 %id)
TI_1948132549   .c 306 to 752 121 to 568       448/1383
(32 %)
15 diff
(99.0 %id)
TI_1948132862   .c 306 to 878 120 to 694       575/1394
(41 %)
14 diff
(99.0 %id)
TI_1948133174   .c 306 to 1034 124 to 858       735/1399
(52 %)
16 diff
(98.9 %id)
CB115153 Liver .c 307 to 857 1 to 551       551/551
(100 %)
8 diff
(98.6 %id)
TI_1948132247   .c 308 to 1034 132 to 859       593/1218
(48 %)
34 diff
(97.3 %id)
BM916236 amelanotic melanoma, cell line, skin .c 309 to 1032 1 to 725       725/771
(94 %)
6 diff
(99.3 %id)
CR995605 T-Lymphocytes .c 309 to 955 1 to 650       650/650
(100 %)
6 diff
(99.1 %id)
BM456893 embryonal carcinoma, cell line, testis .c 310 to 1204 1 to 898       898/1052
(85 %)
25 diff
(97.7 %id)
CV030614 mixed .c 312 to 933 1 to 621       621/626
(99 %)
2 diff
(99.7 %id)
TI_1948132550   .c 312 to 1000 135 to 829       695/1271
(54 %)
14 diff
(98.9 %id)
EC566508 Prostate .c 313 to 415 1 to 103       103/103
(100 %)
4 diff
(96.2 %id)
AB209834 brain .c 315 to 2040 1 to 1726       1726/1726
(100 %)
1 diff
(100.0 %id)
CB145813 Liver .c 315 to 717 1 to 403       403/403
(100 %)
0 diff
(100 %id)
BM544393 brain, hippocampus .c 316 to 1281 15 to 986       972/1053
(92 %)
35 diff
(96.7 %id)
BF969203 adrenal cortex carcinoma, cell line, adrenal gland .c 319 to 890 1 to 572       572/572
(100 %)
0 diff
(100 %id)
EL954819 eyeball .c 330 to 736 31 to 436       406/436
(93 %)
11 diff
(97.5 %id)
CB854116 lung, Primary Lung Epithelial Cells .c 344 to 939 10 to 605     Submitted on the opposite strand 596/605
(98 %)
2 diff
(99.7 %id)
CA950023 Pancreas, Purified pancreatic islet .c 352 to 947 1 to 596       596/596
(100 %)
5 diff
(99.2 %id)
BE315253 adenocarcinoma cell line, ovary .c 356 to 1054 14 to 712       702/712
(98 %)
7 diff
(99.1 %id)
CR594610 Neuroblastoma Cot 25-normalized .c 358 to 2048 1 to 1691   tiling clone,   1691/1691
(100 %)
0 diff
(100 %id)
CR615988 Neuroblastoma Cot 25-normalized .c 358 to 2006 1 to 1649       1649/1649
(100 %)
0 diff
(100 %id)
BX437970 neuroblastoma .c 358 to 1232 1 to 867       867/920
(94 %)
10 diff
(99.0 %id)
BX345378 Neuroblastoma Cot 25-normalized .c 358 to 1230 1 to 870   fully sequenced,   870/870
(100 %)
4 diff
(99.6 %id)
BX333547 Neuroblastoma Cot 25-normalized .c 358 to 1065 1 to 710   fully sequenced,   710/710
(100 %)
3 diff
(99.6 %id)
AL533598 brain, fetal brain .c 358 to 1204 1 to 846       846/877
(96 %)
22 diff
(97.5 %id)
AL534086 brain, fetal brain .c 358 to 1099 1 to 742       742/742
(100 %)
0 diff
(100 %id)
BX460296 brain, fetal brain .c 358 to 1280 1 to 915       915/926
(98 %)
11 diff
(98.9 %id)
CN275411 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 365 to 946 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP207409 coronary artery .c 388 to 968 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BG326200 Kidney, renal cell adenocarcinoma .c 394 to 1074 1 to 682       682/682
(100 %)
4 diff
(99.5 %id)
AA179562   .c 405 to 864 1 to 462       462/463
(99 %)
5 diff
(99.0 %id)
BX333546 Neuroblastoma Cot 25-normalized .c 1035 to 2006 973 to 1   fully sequenced,   973/973
(100 %)
12 diff
(98.8 %id)
AL534085 brain, fetal brain .c 1131 to 1997 868 to 1       868/868
(100 %)
15 diff
(98.3 %id)
BX345377 Neuroblastoma Cot 25-normalized .c 1169 to 2048 888 to 11   fully sequenced,   878/888
(98 %)
2 diff
(99.8 %id)
BX433938 neuroblastoma .c 1364 to 2039 672 to 1       672/744
(90 %)
17 diff
(97.8 %id)
AL533597 brain, fetal brain .c 1504 to 2015 537 to 23       515/748
(68 %)
11 diff
(98.6 %id)
AU145546 whole embryo, mainly head .c 1511 to 2020 512 to 1       512/518
(98 %)
11 diff
(97.9 %id)
AA179514   .c 1579 to 2060 484 to 2       483/484
(99 %)
1 diff
(99.8 %id)
BX419048 brain, fetal brain .d 1 to 622 1 to 622   tiling clone,   622/622
(100 %)
0 diff
(100 %id)
BX434888 brain, fetal brain .d 1420 to 1910 496 to 7   tiling clone,   490/547
(89 %)
17 diff
(96.9 %id)
NM_001144766.2   .e 1 to 1846 1 to 1846 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 1846/1846
(100 %)
0 diff
(100 %id)
DC358507 lung .e 15 to 553 1 to 539   tiling clone,   539/539
(100 %)
0 diff
(100 %id)
CN275408 embryonic stem cells, cell lines H1, H7, andH9 .e 41 to 773 1 to 732       732/732
(100 %)
3 diff
(99.6 %id)
AK298860   .e 53 to 1788 1 to 1736 exact tiling clone,   1736/1736
(100 %)
0 diff
(100 %id)
DC366433   .e 53 to 629 1 to 577       577/577
(100 %)
0 diff
(100 %id)
NR_029431.1   .f 1 to 1989 1 to 1989 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 1989/1989
(100 %)
0 diff
(100 %id)
AK316081 subthalamic nucleus .f 275 to 1746 1 to 1472 M57T     1472/1472
(100 %)
5 diff
(99.7 %id)
DC339323 subthalamic nucleus .f 275 to 834 1 to 560       560/560
(100 %)
5 diff
(99.2 %id)
BC003601 Lymph, Burkitt lymphoma .f 289 to 1972 1 to 1684 exact available from MGC, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 1684/1684
(100 %)
0 diff
(100 %id)
BI226824 Burkitt lymphoma, lymph .f 289 to 1082 1 to 799       799/800
(99 %)
31 diff
(96.2 %id)
BE560802 Burkitt lymphoma, lymph .f 306 to 945 1 to 656       656/856
(76 %)
28 diff
(96.8 %id)
BE267568 Burkitt lymphoma, lymph .f 308 to 982 1 to 670       675/677
(99 %)
10 diff
(98.6 %id)
BE270044 Burkitt lymphoma, lymph .f 308 to 929 1 to 621       621/703
(88 %)
8 diff
(98.9 %id)
BE560927 Burkitt lymphoma, lymph .f 308 to 1102 1 to 795       795/857
(92 %)
22 diff
(97.5 %id)
AL515032 neuroblastoma, placenta .f 355 to 971 1 to 616       616/616
(100 %)
5 diff
(99.2 %id)
BX425034 placenta .f 359 to 1187 5 to 827       827/827
(100 %)
9 diff
(99.0 %id)
AL514526 neuroblastoma, placenta .f 359 to 1253 5 to 900   AAA   900/903
(99 %)
8 diff
(99.2 %id)
CR620632 neuroblastoma .f 359 to 1972 5 to 1618 exact     1618/1618
(100 %)
0 diff
(100 %id)
CR622093 fetal brain .f 359 to 1947 5 to 1593 exact     1593/1593
(100 %)
0 diff
(100 %id)
AL533843 brain, fetal brain .f 359 to 1138 5 to 780   fully sequenced,   780/780
(100 %)
5 diff
(99.4 %id)
AL534443 brain, fetal brain .f 359 to 1158 5 to 802   fully sequenced,   802/802
(100 %)
4 diff
(99.6 %id)
BX460774.
matches multiple genes
brain, fetal brain .f 359 to 1110 5 to 755     also hits gene stawnabu 755/755
(100 %)
1 diff
(99.9 %id)
CF141313 CNCAP(3)T-225 cell line, Prostate .f 360 to 805 1 to 446       446/446
(100 %)
6 diff
(98.7 %id)
CF141098 CNCAP(3)T-225 cell line, Prostate .f 360 to 725 1 to 366       366/366
(100 %)
4 diff
(99.0 %id)
EL735917 mixed .f 361 to 1016 1 to 653       653/657
(99 %)
5 diff
(99.3 %id)
TI_1948225719   .f 361 to 1053 124 to 816   fully sequenced,   693/816
(84 %)
6 diff
(99.3 %id)
TI_1948225862   .f 361 to 987 106 to 734   fully sequenced,   628/733
(85 %)
6 diff
(99.2 %id)
TI_1948226012   .f 361 to 976 126 to 740   fully sequenced,   614/739
(83 %)
6 diff
(99.2 %id)
TI_1948226162   .f 361 to 1041 127 to 807   fully sequenced,   680/806
(84 %)
6 diff
(99.3 %id)
TI_154171738   .f 367 to 1115 77 to 836       760/858
(88 %)
67 diff
(92.2 %id)
TI_154172008   .f 367 to 971 46 to 650       605/605
(100 %)
7 diff
(98.9 %id)
BP205954 coronary artery .f 372 to 952 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP331174 rectum .f 380 to 961 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CN275417 embryonic stem cells, DMSO-treated H9 cellline .f 384 to 912 1 to 529       529/529
(100 %)
0 diff
(100 %id)
AA351967   .f 387 to 651 1 to 265       265/265
(100 %)
0 diff
(100 %id)
DA071268 cerebellum .f 407 to 951 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA141669 alzheimer cortex .f 409 to 955 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BG179122 adenocarcinoma, cell line, Prostate .f 411 to 1096 1 to 675       675/921
(73 %)
14 diff
(98.5 %id)
BE702117 nervous_normal .f 412 to 742 14 to 342       329/342
(96 %)
10 diff
(97.1 %id)
BE702201 nervous_normal .f 416 to 769 1 to 352       352/352
(100 %)
3 diff
(99.2 %id)
BE702095 nervous_normal .f 417 to 758 1 to 341       341/341
(100 %)
3 diff
(99.2 %id)
BE813765 breast_normal .f 417 to 811 2 to 395       394/395
(99 %)
20 diff
(95.0 %id)
BG574205 breast, mammary adenocarcinoma, cell line .f 423 to 1142 1 to 720       720/720
(100 %)
0 diff
(100 %id)
DR761976 embryonic stem .f 440 to 1265 14 to 839       826/839
(98 %)
6 diff
(99.3 %id)
AA359664 lung .f 448 to 671 1 to 225       225/227
(99 %)
3 diff
(98.7 %id)
BF338158 brain, glioblastoma with EGFR amplification .f 464 to 1200 13 to 751       739/936
(78 %)
15 diff
(98.4 %id)
BI087439 cervix .f 465 to 1191 1 to 727       727/728
(99 %)
5 diff
(99.4 %id)
BJ991771 hepatoblastoma .f 468 to 874 1 to 407       407/407
(100 %)
0 diff
(100 %id)
BG679253 skin, squamous cell carcinoma .f 469 to 1205 1 to 738       738/743
(99 %)
3 diff
(99.6 %id)
AA315464 colon .f 473 to 860 1 to 388       388/388
(100 %)
1 diff
(99.8 %id)
EC512465 Prostate .f 484 to 572 1 to 89       89/90
(98 %)
2 diff
(97.8 %id)
EC542061 Prostate .f 484 to 572 1 to 89       89/90
(98 %)
2 diff
(97.8 %id)
BG180281 adenocarcinoma, cell line, Prostate .f 494 to 909 239 to 652       414/652
(63 %)
9 diff
(98.7 %id)
TI_154187884   .f 506 to 1113 151 to 757       607/940
(64 %)
17 diff
(98.2 %id)
BE312842 brain, neuroblastoma .f 508 to 1059 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
CU446219 epidermis .f 512 to 1201 13 to 703       691/703
(98 %)
6 diff
(99.2 %id)
AA324405 brain, cerebellum .f 550 to 865 9 to 323       315/325
(96 %)
9 diff
(97.3 %id)
BQ050494 leiomyosarcoma, uterus .f 566 to 1422 1 to 861       861/1036
(83 %)
10 diff
(99.1 %id)
CB154555 brain .f 585 to 1242 1 to 658       658/658
(100 %)
1 diff
(99.9 %id)
EC501361 Prostate .f 598 to 691 1 to 91       91/91
(100 %)
5 diff
(94.6 %id)
EC458819 Prostate .f 601 to 690 8 to 98       91/98
(92 %)
6 diff
(93.9 %id)
BE782786 eye, retinoblastoma .f 625 to 1260 1 to 634       634/634
(100 %)
7 diff
(98.9 %id)
BG284917 adenocarcinoma, cell line, Prostate .f 631 to 1423 1 to 788       790/791
(99 %)
11 diff
(98.7 %id)
TI_1948133477   .f 663 to 1681 1140 to 123       1018/1250
(81 %)
29 diff
(97.7 %id)
TI_1948135093   .f 671 to 1681 1141 to 122       1018/1277
(79 %)
32 diff
(97.5 %id)
TI_1948133476   .f 674 to 1681 1130 to 118       1013/1168
(86 %)
23 diff
(98.1 %id)
AI863775 Kidney .f 694 to 969 277 to 1       277/277
(100 %)
9 diff
(96.8 %id)
BQ953471 brain, neuroblastoma, cell line .f 701 to 1583 1 to 884       884/895
(98 %)
9 diff
(99.0 %id)
FN111269 breast carcinoma .f 724 to 818 1 to 95       95/95
(100 %)
2 diff
(97.9 %id)
TI_1948133478   .f 727 to 1681 1076 to 122       955/1078
(88 %)
8 diff
(99.3 %id)
BQ434506 leiomyosarcoma, uterus .f 729 to 1583 1 to 860       860/886
(97 %)
18 diff
(98.0 %id)
BI759094 pooled colon, kidney, stomach .f 738 to 1552 1 to 820       820/820
(100 %)
5 diff
(99.4 %id)
TI_57146237   .f 738 to 1552 71 to 890       820/890
(92 %)
11 diff
(98.8 %id)
BQ302294 breast .f 748 to 1378 1 to 633       633/633
(100 %)
3 diff
(99.6 %id)
BQ302305 breast .f 748 to 1378 1 to 633       633/633
(100 %)
3 diff
(99.6 %id)
AW814887 stomach .f 750 to 1264 1 to 524       524/672
(77 %)
18 diff
(97.4 %id)
BE932034 head_neck .f 762 to 1079 1 to 318       318/318
(100 %)
2 diff
(99.4 %id)
BM456423 lymph, lymphoma, cell line .f 780 to 1574 30 to 824       795/826
(96 %)
9 diff
(99.0 %id)
FN114371 breast carcinoma .f 789 to 885 1 to 91       91/91
(100 %)
7 diff
(92.4 %id)
TI_1948134013   .f 790 to 1681 1012 to 121       892/1271
(70 %)
7 diff
(99.5 %id)
TI_1948134558   .f 790 to 1681 1018 to 123       896/1218
(73 %)
8 diff
(99.4 %id)
TI_1948134559   .f 790 to 1681 1014 to 122       893/1089
(82 %)
6 diff
(99.5 %id)
TI_1948134012   .f 791 to 1681 1014 to 118       897/1180
(76 %)
19 diff
(98.4 %id)
TI_1948134557   .f 793 to 1681 1021 to 120       902/1215
(74 %)
15 diff
(98.8 %id)
TI_1948135094   .f 794 to 1681 1010 to 121       890/1093
(81 %)
8 diff
(99.3 %id)
TI_1948134014   .f 797 to 1681 1009 to 122       888/1093
(81 %)
13 diff
(98.9 %id)
TI_1948135092   .f 797 to 1681 1008 to 120       889/1182
(75 %)
14 diff
(98.9 %id)
BF244770 brain, glioblastoma .f 812 to 1489 1 to 672       672/870
(77 %)
18 diff
(98.0 %id)
TI_1948132864   .f 834 to 1681 979 to 119       861/1290
(66 %)
33 diff
(97.5 %id)
FN156757 breast carcinoma .f 841 to 941 101 to 1     Submitted on the opposite strand 101/101
(100 %)
0 diff
(100 %id)
BQ376765 uterus .f 855 to 1366 16 to 527       512/531
(96 %)
8 diff
(98.5 %id)
BQ377021 uterus .f 858 to 1372 4 to 519       516/519
(99 %)
11 diff
(97.9 %id)
BX431841 fetal liver, Liver .f 866 to 1804 1 to 931       929/931
(99 %)
23 diff
(97.6 %id)
FN074942 breast carcinoma .f 868 to 960 1 to 91       91/91
(100 %)
4 diff
(95.7 %id)
BG251924 adenocarcinoma, cell line, Liver .f 872 to 1631 1 to 757       757/810
(93 %)
8 diff
(99.1 %id)
BM799289 Ascites, stomach .f 909 to 1451 1 to 543       543/543
(100 %)
0 diff
(100 %id)
TI_1948226013   .f 915 to 1681 889 to 118   fully sequenced,   772/889
(86 %)
8 diff
(99.2 %id)
BM562069 amelanotic melanoma, cell line, skin .f 934 to 1795 1 to 869       869/1038
(83 %)
24 diff
(97.7 %id)
TI_1948132248   .f 935 to 1681 870 to 120       751/1329
(56 %)
12 diff
(99.1 %id)
BE932091 head_neck .f 955 to 1408 12 to 464       453/464
(97 %)
15 diff
(96.8 %id)
TI_1948225863   .f 957 to 1681 840 to 116   fully sequenced,   725/840
(86 %)
2 diff
(99.8 %id)
BQ707566 Spleen .f 977 to 1874 1 to 906       906/910
(99 %)
17 diff
(98.2 %id)
BM796128 Ascites, stomach .f 979 to 1408 1 to 430       430/430
(100 %)
0 diff
(100 %id)
CB147912 Liver .f 981 to 1599 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
CB147944 Liver .f 981 to 1550 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
BM049969 carcinoma, cell line, Prostate .f 984 to 1792 1 to 816       816/997
(81 %)
28 diff
(97.2 %id)
CB146391 Liver .f 987 to 1526 1 to 540       540/540
(100 %)
3 diff
(99.5 %id)
BM796831 Ascites, stomach .f 988 to 1453 1 to 467       467/467
(100 %)
4 diff
(99.2 %id)
TI_1948226163   .f 1011 to 1681 790 to 119   fully sequenced,   672/790
(85 %)
0 diff
(100 %id)
BF082565 breast .f 1017 to 1324 2 to 307       306/307
(99 %)
6 diff
(98.1 %id)
BF082605 breast .f 1022 to 1324 1 to 300       300/300
(100 %)
6 diff
(98.0 %id)
TI_1948225720   .f 1023 to 1681 779 to 122   fully sequenced,   658/779
(84 %)
0 diff
(100 %id)
BF154436 breast_normal .f 1043 to 1324 4 to 285       282/285
(98 %)
6 diff
(97.9 %id)
BG397476 B-cells, primary B-cells from tonsils (cell line) .f 1047 to 1857 1 to 814       812/814
(99 %)
18 diff
(97.8 %id)
CB105416 Liver .f 1062 to 1632 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
BM468104 melanotic melanoma, skin .f 1080 to 1942 1 to 867       867/871
(99 %)
8 diff
(99.1 %id)
BG876634 denis_drash .f 1082 to 1664 18 to 599       584/599
(97 %)
16 diff
(97.4 %id)
BM797798 Ascites, stomach .f 1085 to 1596 1 to 512       512/512
(100 %)
5 diff
(99.1 %id)
CN275416 embryonic stem cells, DMSO-treated H9 cellline .f 1089 to 1434 1 to 346       346/346
(100 %)
0 diff
(100 %id)
BQ377220 uterus .f 1101 to 1528 16 to 443       428/443
(96 %)
1 diff
(99.8 %id)
AL565274 brain, fetal brain .f 1108 to 1943 840 to 5   fully sequenced,   836/840
(99 %)
10 diff
(98.9 %id)
TI_1948132551   .f 1108 to 1681 703 to 130       574/1362
(42 %)
4 diff
(99.8 %id)
TI_149290786   .f 1108 to 1951 945 to 102   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 844/988
(85 %)
11 diff
(98.9 %id)
TI_149308974   .f 1112 to 1951 905 to 67       839/1090
(76 %)
21 diff
(98.1 %id)
AL534442 brain, fetal brain .f 1128 to 1940 811 to 1   fully sequenced,   811/811
(100 %)
10 diff
(98.8 %id)
CA942245 Pancreas, Purified pancreatic islet .f 1142 to 1607 15 to 480   fully sequenced,   466/480
(97 %)
6 diff
(98.8 %id)
BF912944 uterus_tumor .f 1162 to 1386 1 to 225       225/225
(100 %)
3 diff
(98.7 %id)
CV334631 uterus_tumor .f 1162 to 1667 1 to 506       506/506
(100 %)
0 diff
(100 %id)
BM824291 Ascites, stomach .f 1165 to 1743 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
CV318167 placenta_normal .f 1197 to 1629 1 to 433       437/433
(100 %)
13 diff
(97.0 %id)
BQ365034 placenta_normal .f 1204 to 1573 1 to 370       370/370
(100 %)
3 diff
(99.2 %id)
BQ365052 placenta_normal .f 1205 to 1573 1 to 369       369/369
(100 %)
5 diff
(98.7 %id)
BQ365260 placenta_normal .f 1211 to 1573 1 to 364       364/364
(100 %)
6 diff
(98.4 %id)
AL515031 neuroblastoma, placenta .f 1228 to 1971 745 to 1       745/745
(100 %)
18 diff
(97.6 %id)
BM697879 eye, fetal eyes .f 1229 to 1584 1 to 356     Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 356/356
(100 %)
0 diff
(100 %id)
BQ314774 denis_drash .f 1231 to 1527 1 to 296       296/296
(100 %)
11 diff
(96.3 %id)
AW089598 ovary, tumor, 5 pooled (see description) .f 1243 to 1975 734 to 4       734/734
(100 %)
12 diff
(98.4 %id)
AA301120 testis .f 1247 to 1550 1 to 304       304/304
(100 %)
2 diff
(99.4 %id)
AW959429   .f 1253 to 1810 1 to 561       561/681
(82 %)
40 diff
(94.2 %id)
BG494439 lung, mucoepidermoid carcinoma .f 1253 to 1954 1 to 707       707/803
(88 %)
40 diff
(95.1 %id)
CA306146 Alveolar Macrophage, lung .f 1267 to 1931 683 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 665/665
(100 %)
0 diff
(100 %id)
BX433577 placenta .f 1270 to 1950 676 to 1       676/746
(90 %)
20 diff
(97.4 %id)
BQ316034 colon .f 1275 to 1601 15 to 341       333/341
(97 %)
7 diff
(98.0 %id)
H45227 brain .f 1277 to 1503 1 to 231       231/231
(100 %)
8 diff
(96.6 %id)
AA626400 lung, lung carcinoma .f 1284 to 1576 1 to 292       292/301
(97 %)
6 diff
(98.1 %id)
EC466747 Prostate .f 1368 to 1462 1 to 95       95/95
(100 %)
0 diff
(100 %id)
EC554371 Prostate .f 1368 to 1462 1 to 93       93/93
(100 %)
2 diff
(97.9 %id)
AI831154 lymph node, lymphoma, follicular mixed small and largecell .f 1408 to 1975 567 to 1       567/571
(99 %)
12 diff
(97.9 %id)
AI680409 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f 1416 to 1950 557 to 25   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 533/675
(78 %)
16 diff
(97.7 %id)
AI560032 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 1422 to 1672 251 to 1       251/265
(94 %)
17 diff
(93.6 %id)
AW008900 colon .f 1422 to 1972 555 to 3       553/603
(91 %)
10 diff
(98.4 %id)
BF593721 brain, glioblastoma (pooled) .f 1429 to 1975 548 to 1       548/548
(100 %)
3 diff
(99.5 %id)
AW672740   .f 1437 to 1934 493 to 1       493/496
(99 %)
29 diff
(94.2 %id)
AA846510 parathyroid gland, parathyroid tumor .f 1438 to 1946 509 to 1       509/509
(100 %)
0 diff
(100 %id)
BF935525 nervous_tumor .f 1450 to 1716 1 to 267       267/267
(100 %)
1 diff
(99.7 %id)
BE046304 colon, juvenile granulosa tumor .f 1456 to 1978 533 to 6       528/533
(99 %)
25 diff
(95.4 %id)
EC464730 Prostate .f 1457 to 1553 1 to 96       96/96
(100 %)
2 diff
(98.0 %id)
EC517317 Prostate .f 1457 to 1553 9 to 105       97/105
(92 %)
5 diff
(95.3 %id)
AI686826 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f 1489 to 1672 184 to 1       184/184
(100 %)
1 diff
(99.5 %id)
AA961670 Kidney, kidney tumor .f 1490 to 1931 442 to 1       442/442
(100 %)
2 diff
(99.6 %id)
AA429827   .f 1492 to 1834 1 to 343       343/343
(100 %)
3 diff
(99.2 %id)
AI039433   .f 1498 to 1971 481 to 8       474/481
(98 %)
1 diff
(99.8 %id)
DB512629 testis .f 1503 to 1938 1 to 436     Submitted on the opposite strand 436/436
(100 %)
0 diff
(100 %id)
DB537078 hippocampus .f 1512 to 1938 1 to 427   AAA Submitted on the opposite strand 427/427
(100 %)
1 diff
(99.8 %id)
CK903592 Islets of Langerhans, Pancreas .f 1512 to 1950 454 to 16   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 439/439
(100 %)
2 diff
(99.6 %id)
AI368833   .f 1518 to 1975 463 to 5       459/471
(97 %)
0 diff
(100 %id)
DB574146 hypothalamus .f 1519 to 1976 1 to 459     Submitted on the opposite strand 459/459
(100 %)
2 diff
(99.6 %id)
T34820 brain .f 1534 to 1788 1 to 256       256/256
(100 %)
2 diff
(99.3 %id)
FN094796 breast carcinoma .f 1535 to 1611 1 to 80       80/81
(98 %)
2 diff
(97.6 %id)
AA084572   .f 1537 to 1953 428 to 2       427/428
(99 %)
7 diff
(98.4 %id)
AW198000 adenocarcinoma, Pancreas .f 1537 to 1971 438 to 3       436/438
(99 %)
3 diff
(99.4 %id)
BM665364 eye, Retina Foveal and Macular .f 1544 to 1953 413 to 3       411/422
(97 %)
0 diff
(100 %id)
BM692686 eye, Retina Foveal and Macular .f 1544 to 1860 1 to 317       317/317
(100 %)
0 diff
(100 %id)
BU733996 eye, Retina Foveal and Macular .f 1544 to 1953 413 to 3       411/422
(97 %)
0 diff
(100 %id)
CA844035 Pancreas, Purified pancreatic islet .f 1546 to 1970 426 to 1   fully sequenced,   426/426
(100 %)
1 diff
(99.8 %id)
AW263738 lung, two pooled squamous cell carcinomas .f 1552 to 1971 424 to 3       422/424
(99 %)
0 diff
(100 %id)
AA991525 breast .f 1571 to 1930 360 to 1       360/360
(100 %)
0 diff
(100 %id)
BX343718 Placenta Cot 25-normalized .f 1577 to 1958 1 to 382       382/383
(99 %)
4 diff
(99.0 %id)
BX356635 Placenta Cot 25-normalized .f 1577 to 1958 1 to 382       382/383
(99 %)
4 diff
(99.0 %id)
D20130   .f 1582 to 1934 1 to 355     Submitted on the opposite strand 355/355
(100 %)
2 diff
(99.5 %id)
AW192070 adenocarcinoma, Pancreas .f 1602 to 1953 353 to 1       353/353
(100 %)
1 diff
(99.8 %id)
AA991531 breast .f 1618 to 1930 313 to 1       313/313
(100 %)
0 diff
(100 %id)
AJ714981 bone marrow .f 1619 to 1931 1 to 309       309/309
(100 %)
7 diff
(97.8 %id)
AW450606   .f 1621 to 1931 328 to 18   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 311/320
(97 %)
0 diff
(100 %id)
AA631661 germ cell tumor .f 1634 to 1971 339 to 1       339/340
(99 %)
3 diff
(99.2 %id)
AA738421 pooled germ cell tumors .f 1649 to 1972 325 to 1       325/325
(100 %)
2 diff
(99.4 %id)
EC569427 Prostate .f 1658 to 1766 1 to 108       108/108
(100 %)
4 diff
(96.3 %id)
EC503179 Prostate .f 1660 to 1766 1 to 107       107/107
(100 %)
4 diff
(96.3 %id)
AA729887 pooled germ cell tumors .f 1681 to 1958 278 to 2       277/278
(99 %)
0 diff
(100 %id)
BM667056 eye, fetal eyes .f 1689 to 1931 261 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 243/243
(100 %)
0 diff
(100 %id)
AW841189 colon_normal .f 1691 to 1889 11 to 210       200/210
(95 %)
6 diff
(97.2 %id)
AI245269 Kidney .f 1692 to 1938 261 to 15   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 247/247
(100 %)
0 diff
(100 %id)
BE222729 brain, oligodendroglioma .f 1698 to 1931 234 to 1       234/234
(100 %)
0 diff
(100 %id)
CR984152 T-Lymphocytes .f 1762 to 1974 1 to 214   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 214/214
(100 %)
1 diff
(99.6 %id)
AJ714056 bone marrow .f 1763 to 1971 13 to 220       208/227
(91 %)
2 diff
(99.2 %id)
EC485164 Prostate .f 1769 to 1880 1 to 112       112/112
(100 %)
0 diff
(100 %id)
BG026328 Bone, osteosarcoma, cell line .f 1835 to 1971 1 to 136   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 136/136
(100 %)
3 diff
(97.8 %id)
DC402203 testis .g 1 to 566 1 to 566   tiling clone,   566/566
(100 %)
2 diff
(99.7 %id)
CR609021 fetal brain .g 339 to 1427 1 to 1089   tiling clone,   1089/1089
(100 %)
0 diff
(100 %id)
AK296602 colon .h 1 to 1719 1 to 1719 P5L D261G F362Y F363L tiling clone,   1719/1719
(100 %)
5 diff
(99.8 %id)
DC344771 colon .h 1 to 549 1 to 549       549/549
(100 %)
2 diff
(99.7 %id)
DC387609 small intestine .h 1 to 561 1 to 561       561/561
(100 %)
2 diff
(99.7 %id)
BX443648 T cells (Jurkat cell line) .h 10 to 789 1 to 741       516/741
(69 %)
17 diff
(97.8 %id)
BX456126 T cells (Jurkat cell line) .h 1309 to 1799 492 to 1   tiling clone,   492/524
(93 %)
39 diff
(92.6 %id)
BE704297 nervous_normal .h 1743 to 2106 1 to 365   tiling clone,   365/365
(100 %)
8 diff
(97.9 %id)
BQ300918 bladder_tumor .h 1777 to 2127 48 to 404   tiling clone,   357/412
(86 %)
7 diff
(98.4 %id)
DB022890 testis .i 1 to 556 2 to 557   tiling clone, to resequence, capped   556/556
(100 %)
0 diff
(100 %id)
DB336142 testis .i 1263 to 1798 537 to 1   tiling clone, to resequence,   537/537
(100 %)
1 diff
(99.9 %id)
BU597241 mixed (pool of 40 RNAs) .j 1 to 835 1 to 835   tiling clone,   835/835
(100 %)
12 diff
(98.6 %id)
BP218196 caudate nucleus .j 4 to 587 1 to 584       584/584
(100 %)
16 diff
(97.3 %id)
CX762977 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 34 to 677 1 to 645     Submitted on the opposite strand 645/761
(84 %)
25 diff
(96.8 %id)
BU154974 melanotic melanoma, skin .j 62 to 929 1 to 870   tiling clone,   870/874
(99 %)
11 diff
(98.8 %id)
AW814773 stomach .j 577 to 1092 1 to 520       520/520
(100 %)
12 diff
(97.7 %id)
BM821356 stomach .j 784 to 1338 1 to 555       555/555
(100 %)
4 diff
(99.3 %id)
BM854582 stomach .j 788 to 1240 1 to 453       453/453
(100 %)
0 diff
(100 %id)
BM829836 stomach .j 788 to 1366 1 to 579   tiling clone,   579/579
(100 %)
0 diff
(100 %id)
BM830423 stomach .j 889 to 1031 1 to 143       143/143
(100 %)
1 diff
(99.4 %id)
BM821900 stomach .j 891 to 1049 1 to 159       159/159
(100 %)
1 diff
(99.4 %id)
BM468605 melanotic melanoma, skin .j 1097 to 1870 1 to 775   tiling clone, AAA   775/775
(100 %)
4 diff
(99.5 %id)
CD244549 testis .k 1 to 802 1 to 810   tiling clone,   810/827
(97 %)
15 diff
(98.2 %id)
AI040641 liver and spleen .k 778 to 1218 440 to 1   tiling clone,   440/442
(99 %)
5 diff
(98.9 %id)
BX438581 neuroblastoma .l 1 to 780 3 to 782 exact tiling clone,   782/782
(100 %)
0 diff
(100 %id)
BQ061519 lymph, lymphoma, cell line .l 34 to 769 1 to 746       746/1178
(63 %)
19 diff
(98.4 %id)
AK308016 lung .m 1 to 1058 1 to 1059 V178R Q179T A180G L181S R182Q ... tiling clone,   1059/1059
(100 %)
3 diff
(99.8 %id)
BF753833 colon .n 1 to 103 1 to 102   tiling clone,   102/105
(97 %)
9 diff
(91.5 %id)
BX645089   .n 102 to 704 1 to 604   tiling clone,   604/604
(100 %)
1 diff
(99.9 %id)
AU309531 neuroblastoma .o 1 to 578 16 to 594   tiling clone,   577/600
(96 %)
15 diff
(97.5 %id)
DC352981 brain .o 5 to 570 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
BP378441 uterus .o 5 to 574 1 to 570       570/570
(100 %)
0 diff
(100 %id)
CB045477 colon, juvenile granulosa tumor .o 8 to 403 1 to 397       397/397
(100 %)
4 diff
(99.0 %id)
BQ423841 eye, retinoblastoma .o 38 to 438 1 to 402       402/857
(46 %)
9 diff
(99.0 %id)
CN275418 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 60 to 732 1 to 673 T152P tiling clone,   673/673
(100 %)
1 diff
(99.9 %id)
CK903593 Islets of Langerhans, Pancreas .p 1 to 452 1 to 452 exact tiling clone,   452/452
(100 %)
0 diff
(100 %id)
BI962957 Islets of Langerhans, Pancreas .p 17 to 581 1 to 565       565/565
(100 %)
0 diff
(100 %id)
AI560033 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .p 48 to 705 659 to 1       659/679
(97 %)
33 diff
(95.2 %id)
CB160389 Liver .p 48 to 565 11 to 528       518/528
(98 %)
6 diff
(98.9 %id)
AA931857 Kidney .p 49 to 744 699 to 1       699/699
(100 %)
14 diff
(98.0 %id)
TI_1948132249   .p 52 to 454 520 to 117       404/1415
(28 %)
4 diff
(99.8 %id)
CA425931 cell lines, Chondrosarcoma .p 55 to 723 685 to 17   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 669/669
(100 %)
4 diff
(99.5 %id)
BQ772827 Chondrosarcoma Cell line .p 57 to 711 666 to 12   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 655/655
(100 %)
1 diff
(99.9 %id)
BM825460 Ascites, stomach .p 66 to 609 1 to 544       544/544
(100 %)
0 diff
(100 %id)
BU629661 cell lines, Chondrosarcoma .p 66 to 749 703 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 685/685
(100 %)
1 diff
(99.9 %id)
CV369659 bladder_tumor .p 80 to 556 1 to 476       476/476
(100 %)
6 diff
(98.8 %id)
CV369650 bladder_tumor .p 81 to 556 1 to 475       475/475
(100 %)
9 diff
(98.2 %id)
AI858326 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .p 82 to 744 666 to 3       664/666
(99 %)
12 diff
(98.2 %id)
BG926679 cartilage .p 106 to 665 86 to 645       560/577
(97 %)
8 diff
(98.7 %id)
BU687415 lung .p 114 to 704 609 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 591/591
(100 %)
0 diff
(100 %id)
AW316628 brain, three pooled meningiomas .p 118 to 723 619 to 14   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 606/606
(100 %)
6 diff
(99.1 %id)
BQ445927 Knee, Osteoarthritic Cartilage .p 128 to 762 654 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 636/636
(100 %)
1 diff
(99.9 %id)
AW873099 adrenal gland, neuroblastoma .p 133 to 711 594 to 16   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 579/579
(100 %)
2 diff
(99.7 %id)
AW873107 adrenal gland, neuroblastoma .p 136 to 711 591 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 576/576
(100 %)
2 diff
(99.7 %id)
BU681849 lung .p 145 to 724 599 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 581/581
(100 %)
1 diff
(99.9 %id)
BG926564 cartilage .p 147 to 707 87 to 647       561/577
(97 %)
6 diff
(99.0 %id)
AI686591 serous papillary carcinoma, high grade, 2pooled tumors, uterus .p 155 to 744 595 to 5       591/596
(99 %)
2 diff
(99.7 %id)
BI966782 Islets of Langerhans, Pancreas .p 157 to 723 582 to 16   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 567/567
(100 %)
2 diff
(99.7 %id)
AA903503 pooled germ cell tumors .p 175 to 726 553 to 3       551/553
(99 %)
4 diff
(99.3 %id)
BE540827 cervix .p 179 to 749 1 to 566       566/928
(60 %)
14 diff
(98.5 %id)
CA432692 cell lines, Chondrosarcoma .p 180 to 704 543 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 525/525
(100 %)
0 diff
(100 %id)
AK126179 thymus .q-u 1 to 2563 2 to 2564   tiling clone, available from FLJ,   2564/2564
(100 %)
8 diff
(99.7 %id)
DB129293 thymus .q-u 1 to 549 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BQ881291 dorsal root ganglia .q-u 1867 to 2294 1 to 429   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 429/431
(99 %)
16 diff
(96.3 %id)
DB344471 thymus .q-u 2116 to 2563 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AK093965 uterus .q-u 2216 to 4171 1 to 1957 I23V H39R S59I I60N K61* tiling clone, available from FLJ,   1957/1957
(100 %)
12 diff
(99.4 %id)
DB247189 uterus .q-u 2217 to 2941 2 to 732 I23V H39R S59I I60N K61* capped   731/731
(100 %)
11 diff
(98.5 %id)
DB350769 uterus .q-u 3780 to 4171 397 to 1       397/397
(100 %)
11 diff
(97.3 %id)
AI886074 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .q-u 3805 to 4171 367 to 1   tiling clone,   367/367
(100 %)
1 diff
(99.8 %id)
DC401213 testis .r 1 to 543 1 to 544 L59P tiling clone,   544/544
(100 %)
2 diff
(99.7 %id)
DC391891 Spleen .s 1 to 544 1 to 544 exact tiling clone,   544/544
(100 %)
0 diff
(100 %id)
DA014027 adrenal gland .t-u 1 to 562 2 to 563   tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
DA811772 ovary, tumor tissue .t-u 34 to 846 2 to 815   tiling clone, capped   814/814
(100 %)
5 diff
(99.4 %id)
DA110037 cerebellum .t-u 684 to 1164 27 to 507 exact tiling clone, capped   481/506
(95 %)
0 diff
(100 %id)
AW902868 nervous_normal .t-u 737 to 1069 1 to 332 exact     332/332
(100 %)
8 diff
(97.6 %id)
W28723 eye, retina .t-u 762 to 1269 34 to 542 C32G F58L F69X     509/574
(88 %)
16 diff
(97.3 %id)
BF959332 nervous_normal .t-u 826 to 1114 15 to 303 A4L E5K A6Q E7R A9L ...     289/303
(95 %)
6 diff
(98.1 %id)
AW896213 nervous_normal .t-u 854 to 1486 1 to 631       631/640
(98 %)
6 diff
(99.1 %id)
AW896207 nervous_normal .t-u 860 to 1224 14 to 382       369/411
(89 %)
21 diff
(94.9 %id)
BE702703 nervous_normal .t-u 867 to 1300 1 to 434       434/440
(98 %)
4 diff
(99.1 %id)
BF340126 brain, glioblastoma with EGFR amplification .t-u 939 to 1670 1 to 719       719/833
(86 %)
18 diff
(97.9 %id)
AW897214 nervous_normal .t-u 1110 to 1541 15 to 446       432/446
(96 %)
8 diff
(98.3 %id)
AW897215 nervous_normal .t-u 1110 to 1509 17 to 416       400/416
(96 %)
6 diff
(98.6 %id)
AW897217 nervous_normal .t-u 1110 to 1497 13 to 400       388/400
(97 %)
6 diff
(98.5 %id)
AW897218 nervous_normal .t-u 1110 to 1533 13 to 435       423/436
(97 %)
5 diff
(98.9 %id)
AW897222 nervous_normal .t-u 1110 to 1520 18 to 427       410/427
(96 %)
6 diff
(98.6 %id)
AW897223 nervous_normal .t-u 1110 to 1458 25 to 373       349/373
(93 %)
6 diff
(98.4 %id)
AW897314 nervous_normal .t-u 1110 to 1487 21 to 404       384/404
(95 %)
6 diff
(98.6 %id)
AW897315 nervous_normal .t-u 1110 to 1506 12 to 410       399/410
(97 %)
6 diff
(98.6 %id)
AW897316 nervous_normal .t-u 1110 to 1505 9 to 410       402/410
(98 %)
11 diff
(97.4 %id)
CV311692 nervous_normal .t-u 1110 to 1505 37 to 437       401/437
(91 %)
6 diff
(98.7 %id)
AW897319 nervous_normal .t-u 1113 to 1488 1 to 381       381/381
(100 %)
11 diff
(97.2 %id)
T60668 lung .t-u 1113 to 1256 1 to 143       143/143
(100 %)
6 diff
(95.9 %id)
AW897220 nervous_normal .t-u 1124 to 1559 8 to 443   tiling clone,   436/443
(98 %)
6 diff
(98.7 %id)
TI_149310270   .t-u 1145 to 1962 861 to 56   tiling clone,   806/971
(83 %)
0 diff
(100 %id)
AW897313 nervous_normal .t-u 1203 to 1508 133 to 439       307/439
(69 %)
11 diff
(97.5 %id)
BU688592 lung, Primary Lung Epithelial Cells .t-u 1218 to 1938 734 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 716/716
(100 %)
5 diff
(99.4 %id)
BE702722 nervous_normal .t-u 1257 to 1716 17 to 476       460/485
(94 %)
13 diff
(97.4 %id)
AW898300 nervous_normal .t-u 1357 to 1627 1 to 268       268/268
(100 %)
3 diff
(98.9 %id)
DB370995 ovary, tumor tissue .t-u 1373 to 1938 563 to 1       563/584
(96 %)
13 diff
(97.8 %id)
CV311706 nervous_normal .t-u 1417 to 1525 25 to 133       109/133
(81 %)
9 diff
(93.3 %id)
T57760 lung .t-u 1425 to 1940 521 to 1       521/523
(99 %)
7 diff
(98.7 %id)
DB295357 adrenal gland .t-u 1434 to 1945 512 to 1       512/512
(100 %)
1 diff
(99.9 %id)
AW903845 nervous_normal .t-u 1451 to 1774 1 to 324       324/324
(100 %)
6 diff
(98.2 %id)
AW903916 nervous_normal .t-u 1465 to 1833 1 to 368       368/368
(100 %)
2 diff
(99.5 %id)
BF744307 breast .t-u 1497 to 1843 1 to 346       346/348
(99 %)
10 diff
(97.2 %id)
BF907624 uterus_tumor .t-u 1498 to 1843 23 to 366       344/368
(93 %)
13 diff
(96.5 %id)
AA704434 liver and spleen .t-u 1518 to 1938 421 to 1       421/422
(99 %)
0 diff
(100 %id)
AA664170 lung .t-u 1521 to 1776 256 to 1       256/256
(100 %)
0 diff
(100 %id)
AA610807 thyroid .t-u 1524 to 1881 1 to 358       358/358
(100 %)
2 diff
(99.5 %id)
AA613457 thyroid .t-u 1524 to 1867 1 to 344       344/344
(100 %)
3 diff
(99.2 %id)
AI222139 pooled .t-u 1527 to 1945 433 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 419/419
(100 %)
0 diff
(100 %id)
AA994744 pooled .t-u 1607 to 1944 356 to 19       338/356
(94 %)
0 diff
(100 %id)
AA232785 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .u 1 to 242 1 to 242 exact tiling clone,   242/242
(100 %)
0 diff
(100 %id)
BE927430 colon .u 26 to 341 316 to 1       316/316
(100 %)
6 diff
(98.2 %id)
CN272173 embryonic stem cells, DMSO-treated H9 cellline .u 61 to 489 1 to 429       429/429
(100 %)
6 diff
(98.7 %id)
BE696858 colon .u 110 to 435 1 to 328       328/331
(99 %)
13 diff
(96.1 %id)
BM692713 eye, Retina Foveal and Macular .u 140 to 736 1 to 597   tiling clone,   597/597
(100 %)
0 diff
(100 %id)
AA318000 retina .u 184 to 513 1 to 330       330/330
(100 %)
0 diff
(100 %id)
W27885 eye, retina .u 353 to 805 25 to 487       463/552
(83 %)
15 diff
(97.3 %id)
AL556987.
matches multiple genes
T cells (Jurkat cell line), T cells from T cell leukemia .u 376 to 1371 1 to 997   tiling clone, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base), also hits gene PRKAG1 997/997
(100 %)
1 diff
(99.9 %id)
BM711799 eye, human retina .u 491 to 1019 1 to 529       529/529
(100 %)
2 diff
(99.7 %id)
TI_149290951   .u 660 to 1371 789 to 79   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 711/712
(99 %)
4 diff
(99.5 %id)
BU734015 eye, Retina Foveal and Macular .u 669 to 1389 711 to 1       711/711
(100 %)
10 diff
(98.6 %id)
BM665383 eye, Retina Foveal and Macular .u 681 to 1389 707 to 1   tiling clone,   707/707
(100 %)
2 diff
(99.8 %id)
FN075174 breast carcinoma .u 701 to 795 1 to 95       95/95
(100 %)
3 diff
(96.9 %id)
FN048469 breast carcinoma .u 702 to 797 1 to 96       96/96
(100 %)
0 diff
(100 %id)
BU681985 lung .u 741 to 1389 648 to 1       648/648
(100 %)
3 diff
(99.6 %id)
AI633507 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .u 896 to 1371 476 to 1       476/476
(100 %)
0 diff
(100 %id)
AW439268 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .u 897 to 1375 479 to 1       479/479
(100 %)
0 diff
(100 %id)
AA626252   .u 937 to 1372 436 to 1       436/436
(100 %)
0 diff
(100 %id)
AA639418 colon, colon tumor RER+ .u 960 to 1370 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AW262249 lung, two pooled squamous cell carcinomas .u 961 to 1374 414 to 1       414/414
(100 %)
0 diff
(100 %id)
FN164713 breast carcinoma .u 996 to 1090 96 to 4     Submitted on the opposite strand 93/96
(96 %)
0 diff
(100 %id)
AI358521 serous papillary carcinoma, high grade, 2pooled tumors, uterus .u 1001 to 1375 375 to 1       375/375
(100 %)
3 diff
(99.2 %id)
AA233346 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .u 1078 to 1371 294 to 1       294/294
(100 %)
0 diff
(100 %id)
AA579355   .u 1094 to 1383 291 to 1       291/291
(100 %)
2 diff
(99.4 %id)
BM746604 Ascites, stomach .u 1099 to 1371 1 to 273   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 273/273
(100 %)
0 diff
(100 %id)
TI_149294040   .va-u 1 to 752 793 to 44 V70S tiling clone,   750/793
(94 %)
0 diff
(100 %id)
CB854854 lung .va-u 146 to 752 609 to 3 V70S     607/609
(99 %)
0 diff
(100 %id)
AI393917 B-cell, chronic lymphotic leukemia .va-u 305 to 725 421 to 1 exact     421/421
(100 %)
2 diff
(99.6 %id)
DA583419 lung .va-u 482 to 1062 2 to 582 exact tiling clone, capped   581/581
(100 %)
0 diff
(100 %id)
DB237911 trachea .vb 1 to 471 2 to 474   tiling clone, capped   473/473
(100 %)
4 diff
(99.2 %id)
DB447596 testis .vb 310 to 740 1 to 433 L73S R74Q M75D A76G P77S ... tiling clone,   433/435
(99 %)
3 diff
(99.4 %id)
DA225927 brain .vc 1 to 540 2 to 541 exact tiling clone, capped   540/540
(100 %)
0 diff
(100 %id)
BG460390   .vd-u 1 to 488 1 to 491   tiling clone,   491/821
(59 %)
42 diff
(94.9 %id)
N51470 multiple sclerosis lesions .vd-u 17 to 496 1 to 482 Y45E R49K F50V K51Q M52N ... tiling clone, Submitted on the opposite strand 482/482
(100 %)
5 diff
(99.0 %id)
AW582593 stomach .ve-u 1 to 388 34 to 421 C9G H45Q A46C C47L V48C tiling clone,   388/602
(64 %)
9 diff
(98.6 %id)
BF091261 testis_normal .vf-u 1 to 208 1 to 208 E6G tiling clone,   208/223
(93 %)
8 diff
(96.5 %id)
AV709361 adrenal gland Gene DNAJC7, variant not shown         Suspected internal deletion, this clone was ignored    
DB319265 lung Gene DNAJC7, variant not shown         Suspected internal deletion, this clone was ignored    
DA582672 lung Gene DNAJC7, variant not shown       capped Suspected internal deletion, this clone was ignored    
BP305864   Gene DNAJC7, variant not shown       AAA This clone was ignored    
DB327062 brain Gene DNAJC7, variant not shown         Submitted on the opposite strand    
DB237042 trachea Gene DNAJC7, variant not shown       capped      
DB350367 trachea Gene DNAJC7, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q-u, .r, .s, .t-u, .u, .va-u, .vb, .vc, .vd-u, .ve-u, .vf-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI